The North America Electronic Clinical Outcome Assessment Solution Market (eCOA) would witness market growth of 18.3% CAGR during the forecast period (2020-2026).
With an aim to collect patient data during clinical trials & observation studies, there is high utilization of eCOAs, including electronic ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), and ePROs (electronic Patient Reported Outcomes). The eCOA solutions are easily available and simple to use due to the technological advancements in the domain of eCOA. The paper-based methods have witnessed a low demand in recent years, & this fact shows a range of advantages achieved through the usage of electronic technologies. Therefore, the market growth is anticipated to be fuelled due to these consistent technological advancements to offer an effective workflow. Some other parameters that fuel the market growth such as growing utilization of clinical trials studies by big pharma companies, biopharmaceutical companies, and increasing demand for cloud-based services.
Moreover, assessment systems are beneficial in detecting probable adverse conditions in advance for patients, which is essential in order to take preventive measures to minimize adverse effects in coming years. Using ePRO systems, real-time data of patients can be transferred from the patients to healthcare professionals with an aim for precise decision-making and the right assessment of a patient’s health. Hence, these determinants would encourage the adoption of these platforms over the upcoming years.
The growth of the eCOA market would witness bright prospects due to many factors such as high R&D spending by pharmaceutical companies, increasing adoption of software solutions during research studies, a broad customer base, and supportive government investments to support clinical trials. Also, the market growth is driven by the growing deployment of eCOA by medical research professionals.
Based on Delivery Mode, the market is segmented into Web-hosted eCOA, Cloud-based eCOA, and Licensed enterprises eCOA. Based on End Use, the market is segmented into Contract Research Organizations (CROs), Hospitals, Academic Institutes, Pharma & Biotech Companies and Medical Device Manufacturers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Licensed enterprises eCOA Market by Country in 2019, thereby, achieving a market value of $69.8 Million by 2026. The Canada market is experiencing a CAGR of 22.3% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 21.4% during (2020 - 2026).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Dassault Systemes SE, IQVIA Holdings, Inc., Parexel International Corporation (Pamplona Capital Management), IBM Corporation (Merge Healthcare), Signant Health, ERT Clinical, eClinical Solutions LLC, Castor EDC and Anju Software, Inc. (OmniComm Systems).
Scope of the Study
Market Segments covered in the Report:
By Delivery Mode
• Web-hosted eCOA
• Cloud-based eCOA
• Licensed enterprises eCOA
By End Use
• Contract Research Organizations (CROs)
• Academic Institutes
• Pharma & Biotech Companies
• Medical Device Manufacturers
• Rest of North America
• Oracle Corporation
• Dassault Systemes SE
• IQVIA Holdings, Inc.
• Parexel International Corporation (Pamplona Capital Management)
• IBM Corporation (Merge Healthcare)
• Signant Health
• ERT Clinical
• eClinical Solutions LLC
• Castor EDC
• Anju Software, Inc. (OmniComm Systems)
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
384 pages •
By Global Industry Analysts
• Apr 2021
- The global Label-Free Detection market is projected to reach US$1.3 billion by 2025, driven by growing drug R&D, rising competitive pressure to reduce cost of drug development and the resulting need for cost-effective and efficient screening technologies. Traditional label-based assays are beset with drawbacks...
The Europe microplate readers market is expected to reach US$ 175.96 million by 2027 from US$ 139.69 million in 2019; it is estimated to grow at a CAGR of 3.0% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing incidence of infectious diseases and consistent research in drug discovery activities....
The manufacturing execution system market is expected to grow from USD 11.5 billion in 2021 to USD 17.1 billion by 2026 at a CAGR of 8.3% from 2021 to 2026. A few key factors driving the growth of this market include increasing use of industrial automation in process and discrete industries, increasing IT and OT convergence, and the need for...
The Asia Pacific microplate readers market is expected to reach US$ 152.15 million by 2027 from US$ 110.87 million in 2019; it is estimated to grow at a CAGR of 4.1% from 2020 to 2027. The growth of the market is attributed to the factors such as technological advancements in microplate readers and consistent research in drug discovery activities....
The Middle East and Africa microplate readers market is expected to reach US$ 19.79 million by 2027 from US$ 16.24 million in 2019; it is estimated to grow with a CAGR of 2.6% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing incidence of infectious diseases and consistent research in...
The ePRO, epatient diaries, and eCOA market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.08% during 2020-2028. Increasing demand for electronic health records (EHRs) and rising use of smartphones are fueling the market growth. However, concerns...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The Asia Pacific Electronic Clinical Outcome Assessment Solution Market (eCOA)would witness market growth of 20.6% CAGR during the forecast period (2020-2026). With an aim to gather patient data in a clinical trial, an eCOA solution is utilized. The global electronic clinical outcome assessment (eCOA) solutions market is anticipated...
Medical Technology Density
Health Provider Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.